Literature DB >> 1717081

Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis.

E F Srour1, J E Brandt, R A Briddell, T Leemhuis, K van Besien, R Hoffman.   

Abstract

Human bone marrow cells expressing CD34 but not HLA-DR were isolated by immunofluorescence flow cytometric cell sorting. These cells contained a hematopoietic cell (CFU-B1) capable of producing, in an in vitro semisolid culture system, blast-cell-containing colonies, which possessed the capacity for self-renewal and commitment to multipotential differentiation. In addition, CD34+ HLA-DR- marrow cells contained primitive megakaryocyte progenitor cells, the burst-forming unit-megakaryocyte (BFU-MK). A subset of CD34+ HLA-DR- marrow cells lacking the expression of CD15 and CD71 was obtained by flow cytometric cell sorting and was capable of sustaining in vitro hematopoiesis in suspension culture for up to 8 weeks in the absence of a preestablished adherent marrow cell layer. The combination of IL-3 + IL-1 alpha and IL-3 + IL-6 sustained proliferation of these cells for 8 weeks, induced maximal cellular expansion, and increased the numbers of assayable progenitor cells. These studies demonstrate that human CD34+ HLA-DR- marrow cells and their subsets contain primitive multipotential hematopoietic cells capable of self-renewal and of differentiation into multiple hematopoietic lineages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717081

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  17 in total

Review 1.  Peripheral blood stem cells: phenotypic diversity and potential clinical applications.

Authors:  Yichi Zhang; Bing Huang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 2.  To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma.

Authors:  C Piccoli; F Agriesti; R Scrima; F Falzetti; M Di Ianni; N Capitanio
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 3.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

4.  Using mitochondrial activity to select for potent human hematopoietic stem cells.

Authors:  Jiajing Qiu; Jana Gjini; Tasleem Arif; Kateri Moore; Miao Lin; Saghi Ghaffari
Journal:  Blood Adv       Date:  2021-03-23

5.  A cellular model for drug interactions on hematopoiesis: the use of human umbilical cord blood progenitors as a model for the study of drug-related myelosuppression of normal hematopoiesis.

Authors:  M C Léglise; P Darodes de Tailly; J L Vignot; M A Le Bot; A M Le Roux; C Riché
Journal:  Cell Biol Toxicol       Date:  1996-02       Impact factor: 6.691

6.  The purification and characterization of fetal liver hematopoietic stem cells.

Authors:  S J Morrison; H D Hemmati; A M Wandycz; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 7.  Identification of haemopoietic stem cells.

Authors:  S Eridani; F Morali
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 8.  Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies.

Authors:  Britta Will; Ulrich Steidl
Journal:  Best Pract Res Clin Haematol       Date:  2010-09       Impact factor: 3.020

9.  Protection and rescue from 2',3'-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells.

Authors:  D A Fowler; M Y Xie; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

10.  Differences in activation and tissue homing markers of natural killer cell subsets during acute dengue infection.

Authors:  Rassamon Keawvichit; Ladawan Khowawisetsut; Sakaorat Lertjuthaporn; Kanchana Tangnararatchakit; Nopporn Apiwattanakul; Sutee Yoksan; Ampaiwan Chuansumrit; Kulkanya Chokephaibulkit; Aftab A Ansari; Nattawat Onlamoon; Kovit Pattanapanyasat
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.